CGONCG Oncology, Inc.
$63.86+73% 1Y
$63.86
$36.4852 weeks$80.66
Is the price fair?
What CGON's price assumes
CG Oncology, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 1032× revenue.
1032
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 6.24
Price / book · today's price, trailing year to Jun 30, 2026
- EV / sales
- 867
EV / sales
Details›
- Price / booktoday's price, trailing year to Jun 30, 2026
- 6.24
- EV / EBIToperating margin −4056%: the multiple describes the denominator
- not meaningful
- EV / salestoday's price, trailing year to Jun 30, 2026
- 867
- Market capitalisation
- $6.42B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
On our screens:Most shorted stocks
Biotechnology
The closest names by size in the same industry